Patent · US Active

TRPV4 antagonists

US10590077B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2017
Grant dateMar 17, 2020
Priority date—
Expiry dateSep 20, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to pyrrolidine sulfonamide analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.